Efficacy and Safety of CHF 6532 in Patients With Uncontrolled Severe Eosinophilic Asthma

NCT04049175 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

810

Enrollment

INDUSTRY

Sponsor class

Stopped An interim analysis run by an independent data monitoring committee (DMC) to assess futility met the protocol-defined futility rules. The DMC recommended to stop the study for futility. The Sponsor issued a notification of early study termination.

Conditions

Asthma; Eosinophilic

Interventions

DRUG: Treatment A
DRUG: Treatment B
DRUG: Treatment C
DRUG: Treatment D

Sponsor

Chiesi Farmaceutici S.p.A.